References
- Calfee JE. An assessment of direct-to-consumer-advertising of prescription drugs. Clin Pharmacol Ther 2007;82:357–60.
- Berger PL, Luckmann T. The social construction of reality. New York, NY: Anchor Books; 1966.
- Sharf B, Vanderford M. Illness narratives and social construction of health. In: , Thompson TL, Dorsey AM, Miller KI, Parrott R, (eds.) Handbook of health communication. NJ: Lawrence Erlbaum Associates; 2003. p. 9–13.
- Mortensen D. Communication: the study of human communication. (Ch. 2, Communication Models). New York: McGraw-Hill; 1972.
- Moynihan R, Smith R. Too much medicine. BMJ 2002;342:859–60.
- Payer L. Selling sickness. Disease-mongers: how doctors, drug companies, and insurers are making you feel sick. Hoboken, NJ: John Wiley & Sons, Inc; 1992.
- Cassels R, Moynihan A. Selling sickness: how drug companies are turning us all into patients. London, UK: Allen & Unwin; 2005.
- Connor E, Khaw K. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 1988;128(1):116–23.
- Donohue J, Cevassco M, Rosenthal M. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 2007;357(7):673–81.
- Illich I, Paton A. Medicalization of health. BMJ 1974;7:573–7.
- Pho K. DTC advertising, and its history with the FDA [cited 2012 Jan 25]. Available from: http://www.kevinmd.com/blog/about-kevin-md
- Payton A, Thoits P. Medicalization, direct-to-consumer advertising, and mental illness. Stigma Soc Ment Health 2011;1(1):55–70.
- Humphreys G. Direct-to-consumer advertising under fire. Bull World Health Organ 2009;87(8):576–7. doi: i10.2471/BLT.09.040809.
- Hollen MF. Direct-to-consumer advertising a haphazard approach to health promotion. J Am Med Assoc 2005;293(16):2030–3. doi: i10.1001/jama.293.16.2030.
- Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, et al. Influence of patient's request for direct-to-consumer advertised antidepressants. J Am Med Assoc 2005;293(16):1995–2002. doi: i10.1001/jama.293.16.1995.
- Simons G. Conceptual modeling versus visual modeling: a technological key to building consensus. Paper presented at the Consensus ex Machina Joint International Conference of the Association for Literary and Linguistic Computing and the Association for Computing and the Humanities. Paris, France; 1994. Computer and Humanities 1996;30(4):303–19, Springer Netherlands. DOI: 10.1007/BF00115139.
- Shannon CE. The mathematical theory of communication. Bell Syst Tech J 1948;27(21):379–423.
- Berlo D. The process of communication. New York, NY: Holt, Rinehart and Winston Publishers; 1960.
- Bryant J, Dorina M. Theory and research in mass communication. J Commun 2004;4(54):662–704. Available from: http://onlinelibrary.wiley.com/doi/10.1111/jcom.2004.54.issue-4/issuetoc.
- Schramm W. The science of human communication. New York: Basic Books; 1963.
- Wells A, Hakanen E. Mass media and society. New York, NY: Ablex; 1977.
- Shelby A. The theoretical bases of persuasion: a critical introduction. J Bus Commun 1986;1(23):5–29. doi: i10.1177/002194368602300102.
- Westley BH, MacLean MS A conceptual model for communications research. Journalism Q 1957;34:31–38.
- Petty RE, Cacioppo JT. The elaboration likelihood model of persuasion. New York, NY: Academic Press; 1986.
- Esposito R, Mcadoo H, Scher L. The johari window test: a research note. J Humanistic Psychol 1978;18(1):79–81.
- Fazio RH. How do attitudes guide behavior? In: , Sorrentino RM, Higgins ET, (eds.) The handbook of motivation and cognition: foundations of social behavior. New York: Guilford Press; 1986. p. 204–43.
- DuPre A. Communicating about health: current issues and perspectives. New York, NY: McGraw-Hill; 2009.
- Cline RJ, Young HN. Direct-to-consumer print ads for drugs: do they undermine the physician-patient relationship? Among the many messages in DTC print ads is: communicate with, and listen to, your physician. J Fam Pract 2005;12(54):1049–57 [cited 2012 Mar 18]. Available from: http://findarticles.com/p/articles/mi_m0689/is_12_54/ai_n27862345/?tag=content;col1.
- Murphy A, Khalfa J. History of madness. In: , Beaulieu, Fillion, (ed.) Foucault studies. New York, NY: Routledge; 2008. p. 74–89.
- Foucault M. The birth of the clinic. London: Routledge; 1963.
- Colucci M. Medicalization. J Sci Commun 2006;5(1):1–5.
- Davies T, Leeder D. Medicine and the state: roles & limits of medicine. New York, NY: Cambridge University Press; 1992.
- Niamtu J, Woodward J, Biesman B, Martin J, Randal P, Raminder S, et al. Aesthetic lasers and other devices for facial rejuvenation. In Don Kikkawa (Chair), Oculofacial Plastic Surgery in the New Decade: Technology, Innovation, Inspiration. Symposium conducted at the meeting of the American Society of Ophthalmic Plastic and Reconstructive Surgery. Chicago, IL; 2010, Oct.
- Niamtu J. Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg 2003;61(3):317–24.
- Niamtu J. Long luscious lashes. Aesthetic Practitioner News; 2009. Available from: http://www.lovethatface.com/_media/pdfs/ADNLatisse6-09.pdf.
- Ornstein C, Weber T. Lawsuits say pharma illegally paid doctors to push their drugs. 2010. Available from: http://www.propublica.org/article/lawsuits-say-pharma-illegally-paid-doctors-to-push-their-drugs.
- ProPublica. Dollars for docs: how industry money reaches physicians. 2011. Available from: http://www.propublica.org/article/get-dollars-for-docs-data.
- Woloshin S, Schwartz l. Giving legs to restless legs: a case study of how the media helps make people sick. Public Lib Sci Med 2006;3(4):170.
- Bradley I. Personal responsibility and medicine today [cited 2012 Feb 8]. Available from: http://www.clinicalcorrelations.org/?p=4849.
- Weber L. Profits before people? Ethical standards and the marketing of prescription drugs. Bloomington: Indiana University Press; 2006.
- Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e724. 17581453.
- Depressive Disorders. NIH Publication No. NIH-99-3561, National Institutes of Health. 1999.
- Kupfer J, Baltimore R, Berry D, Breslau N, Ellinwood E, et al. Diagnosis and treatment of attention deficit hyperactivity disorder. Natl Ins Health Consens Statement 1998;16(2):1–37.
- IMS Health. The use of medicines in the united states: review of 2010 [cited 2011 Jan 11]. Available from: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/IMS%20Institute/Static%20File/IHII_UseOfMed_report.pdf. 2010.
- Pfizer Inc. Annual Financial Report. Available from: http://www.pfizer.com/files/annualreport/2010/financial/financial2010.pdf. 2010.
- Burton B, Rowel A. Disease mongering. PR Watch 2003;10:1–3.
- Erectile dysfunction: the Viagra™ revolution. (2005, Apr 9). Harvard Men's Health Watch, (9), 1–6. Available from: www.ncbi.nlm.nih.gov/pubmed/18217258.
- IMS Health. Top line industry data: total U.S. promotional spend by type, 206 [cited 2010 Oct 23]. Available from: http://imshealth.com/ims/portal/front/articleC/0,2777,6599_80402580_814932500html. 2007.
- Khanfar NM, Polen HH, Clausen KA. Influence on consumer behavior: the impact of direct-to-consumer advertising on medication requests for gastro esophageal reflux disease and social anxiety disorder. J Health Commun 2009;14(5):451–60.
- Rose N. Beyond medicalization. Lancet 2007;369(9562):700–3.
- Palumbo F, Mullins C. Analyzing the laws, regulations, and policies affecting FDA-regulated products: the development of direct-to-consumer prescription drug advertising regulation. Food Drug Law J 2002;57(3):200.
- Wood JT. Gendered media: the influence of media on views of gender. In: , Wood J (ed.), Gendered lives: communication, gender, and culture. New York: Wadsworth Publishing; 1994. p. 31–41.
- Tiefer L. The opposite of sex. In: , Brennan M, (ed.) Ms. Magazine. August–September [cited 2012 Jan 25]. Beverly Hills, CA. Available from: http://www.msmagazine.com/aug99/sex-oppositeofsex.asp. 2009. p. 1–6.
- Schwartz VE, Silverman C, Michael J, Appelle C. Marketing pharmaceutical products in the twenty-first century: an analysis of the continued viability of traditional principles of law in the age of direct-to-consumer advertising. Harv J Law Public Policy 2009;32(1):333–62.
- Moynihan R, Henry D. The fight against disease mongering: generating knowledge for action. Public Lib Sci Med 2006;3(4):e191.
- O'Connor A. Restless legs: uncomfortable and overlooked. The New York Times – Breaking News, World News & Multimedia; 2004 [cited 2010 Sep 28]. New York, NY. Available from: http://www.nytimes.com/2004/05/25/health/25legs.html?ex=1141448400&en=2bf6d431bc7f2b69&ei=5070.
- Martinez L, Lewis N. The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth. J Health Commun 2009;14:246–61.
- Morris L, Pines W. Regulation of pharmaceutical promotion in the twenty-first century. Drug Inf J 2000;34:861–73.
- Brownfield ED, Bernhardt J, Phan JL, Williams M, Parker R. Direct-to-consumer drug advertisements on network television: an exploration of quality, frequency, and placement. J Health Commun 2004;9:491–7.
- Gellad Z, Lyles K. Direct-to-consumer-advertising of pharmaceuticals. Am J Med 2007;120:475–80.
- Manganello JA, Blake N. A study of quantitative content analysis of health messages in United States media from 1985–2005. Chicago, IL; Health Communication, 2010;25(5):387–96.
- Tiefer L. Sex is not a natural act. Boulder, CO: Westview Press; 2004.
- Brennan M. The opposite of sex. Ms. Magazine. August–September, 2009 [cited 2012 Jan 25]. Available from: http://www.msmagazine.com/aug99/sex-oppositeofsex.asp. 2009. p. 1–6.
- Cline RJ, Young HN. Marketing drugs, marketing health care relationships: A content analysis of visual cues in direct-to-consumer prescription drug advertising. Health Commun 2004;16(2):131–57.
- Linden M. Post-traumatic embitterment disorder. J Psychother Psychosomatics 2003;72(4):195–202.
- Rosenthal M, Berndt E, Donohue J, Frank R, Epstein A. Promotion of prescription drugs to consumers. N Eng J Med 2002;346(7):498–505.
- Berndt E, Cockburn I, Gritiches Z, Keeler T, Bailey M. Pharmaceutical innovations and market dynamics: tracking effects on price indexes for antidepressant drugs. Brookings Papers on Economic Activity 1996;1:133–99.
- Naish J. Hypochondria can kill: a disease for every occasion, an illness for every symptom. New York, NY: Penguin Group; 2005.
- Nutraceutical Industry Report. Overview of Nuetracuetical Industry [cited 2010 Dec 1]. Available from: http://www.docstoc.com/docs/9967204/Nutraceutical-Industry-Report. 2009.
- Hulko W. From doctor to ‘silly patient’: seeing beyond the disease label. Int J Epidemiol 2005;34(1):36–9.
- Illich J. Medical nemesis. Epidemical Community Health 2003;57:919–22.
- Virginia State Board of Pharmacy v. Virginia Citizens Consumer Council. 425 U.S. 748. 1976.
- Food and Drug Administration Safety Act of 2007. 110th Congress, S 468.
- Frances A. Advice to dsm-v:change. Psychiatric Times 2009;26(1):4. Available from: http://www.psychiatrictimes.com/display/article/10168/14483.